Current role
Biotechnology · Healthcare
Board Member
2026-03-12–present
Henry Brem
Board Member
Galectin Therapeutics Inc (GALT)Equibles does not estimate personal net worth.
Get an email with a short summary when Galectin Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get GALT alertsAbout Henry Brem
Henry Brem is recorded as Board Member at Galectin Therapeutics Inc (GALT) since March 12, 2026. The newest filing on record that lists Henry Brem as Board Member at Galectin Therapeutics Inc (GALT) is dated October 13, 2026. Galectin Therapeutics Inc reported in an 8-K filed March 17, 2026 that Henry Brem was appointed member of the Board of Directors, effective March 12, 2026. Galectin Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Galectin Therapeutics Inc includes Joel Lewis (CEO and Board Member), Jack W. Callicutt (CFO), Benjamin S. Carson (Board Member) and 7 others.
“On March 12, 2026, the Board of Directors of Galectin Therapeutics Inc. (the "Company") appointed Dr. Henry Brem to serve as a member of the Board of Directors, effective immediately.”
Affiliation history
-
Current
2026-03-12–present
Last confirmed October 13, 2026
Company network
Leadership on record at Galectin Therapeutics Inc
- Joel Lewis CEO, Board Member
- Jack W. Callicutt CFO
- Benjamin S. Carson Board Member
- Dr. Henry Brem Board Member
- Elissa J. Schwartz Board Member
- Gilbert F. Amelio Board Member
- Gilbert S. Omenn Board Member
- Harold H. Shlevin Board Member
- Kary Eldred Board Member
- Kevin D. Freeman Board Member